+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia



Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia



Journal of HematoTherapy 6(5): 495-500



In our laboratory, a two-step procedure is used for purging precursor B ALL from autologous bone marrow grafts of children in second bone marrow remission. An immunorosette depletion method with CD19 and CD22 MAbs is followed by one cycle of complement-mediated cell lysis with CD9 and CD10 MAbs. The aim of the present study was to determine if the efficacy of this procedure could be further enhanced by including CD20 and CD72 MAbs in the current protocol. Leukemia-contaminated remission bone marrow was simulated by mixing cell line cells and normal bone marrow cells. The efficacy of purging of malignant cells was determined by culturing the cells in a limiting dilution assay. The effect of including CD20 and CD72 in the immunorosette depletion was limited. In contrast, when these MAbs were added during complement-mediated cell lysis, a significant increase in depletion of tumor cells was observed. This was true when complement lysis was carried out alone (0.4 versus 3.0 log depletion for Ros cells) and when it was preceded by immunorosette depletion (2.7 versus 4.1 log depletion for Ros cells). The loss of hematopoietic progenitor cells was not greater than with the current purging protocol.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046874294

Download citation: RISBibTeXText

PMID: 9368186

DOI: 10.1089/scd.1.1997.6.495


Related references

Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia. Nouvelle Revue Francaise D'hematologie 32(5): 353-355, 1990

Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia. Progress in Clinical and Biological Research 377: 57-62, 1992

Autologous bone marrow purging with immunotoxins in acute lymphoblastic leukemia. Champlin, R E And R P Gale (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 137 New Strategies in Bone Marrow Transplantation; Sandoz-Ucla Symposium, Keystone, Colorado, Usa, January 20-27, 1990 Xxiii+457p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 39-50, 1991

Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging. Progress in Clinical and Biological Research 389: 125-132, 1994

Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 76(9): 1723-1733, 1990

Marrow purging in autologous bone marrow transplantation for t lineage acute lymphoblastic leukemia efficacy of ex vivo treatment with immunotoxins and 4 hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells. Blood 69(1): 361-366, 1987

Novel leukemic progenitor cell assays to optimize and standardize ex vivo marrow purging in autologous bone marrow transplantation for acute lymphoblastic leukemia. Journal of Cellular Biochemistry Supplement (10 PART D): 221, 1986

Autologous bone marrow transplantation in high risk remission b lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies ba 1 cd24 ba 2 cd9 and ba 3 cd10 plus complement and 4 hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood 79(4): 1094-1104, 1992

Ex vivo marrow purging in autologous bone marrow transplantation for acute lymphoblastic leukemia use of novel colony assays to test the anti leukemic efficacy of various strategies. Gale, R P And R Champlin (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 53 Progress in Bone Marrow Transplantation; Fourth International Symposium, Keystone, Colorado, Usa, April 13-18, 1986 Xxxv+1012p Alan R Liss, Inc : New York, New York, Usa Illus 759-772, 1987

Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia. Progress in Clinical and Biological Research 377: 163-168, 1992

Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia. Chinese Medical Journal 103(5): 385-390, 1990

Purging of autologous bone marrow and peripheral blood stem cells in patients with BCR/ABL-positive acute lymphoblastic leukemia. Annals of Hematology 77(SUPPL 2): S163, 1998

Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow. Progress in Clinical and Biological Research 377: 41-47, 1992